Compare Boston Scientific Corporation (BSX) vs PayPal Holdings, Inc. (PYPL) Price & Performance

Boston Scientific (BSX) trades at $44.65, down 0.27% with bearish technical signals despite strong fundamentals. The company delivered three consecutive earnings beats with Q3-Q1 2026 EPS exceeding expectations, while revenue grew to $20.07B in 2025 with improving profit margins. Technical indicators show bearish momentum with support at $44 and resistance at $45, though Wall Street maintains 88% buy rating with $70.20 consensus target.

BSX presents a compelling value opportunity with attractive valuation multiples (P/E 18.68, P/S 3.24) and robust financial health, though near-term headwinds include competitive pressures in key segments and recent stock price decline of nearly 60% from 2025 highs. The strong analyst consensus suggests significant upside potential if execution improves.

PayPal (PYPL) trades at $47.65, up 2.87% on the day, with a bullish technical signal from moving averages but overbought RSI readings near 78. The stock shows strong fundamentals with a P/E of 8.94, net income margin of 15%, and consistent revenue growth to $33.17B in 2025. Recent news includes a potential acquisition offer from Stripe and Advent at $60.50 per share, valuing the company over $53 billion, alongside expansion of BNPL services in the UK.

PYPL presents a compelling value opportunity with low valuation multiples and solid profitability, though execution risks and competitive pressures remain. The acquisition speculation adds upside potential, but investors face volatility from earnings misses and regulatory scrutiny. Wall Street sentiment is mixed with a $48.36 consensus target, slightly above the current price.